Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. reported net sales of $8.23 billion for fiscal year 2025, generating operating profit of $1.10 billion and net earnings of $705.1 million. The company's operating cash flow was strong at $1.70 billion, though significant investing activities of $1.98 billion, primarily for business combinations, resulted in a net cash outflow from investing. The balance sheet shows total assets of $23.09 billion with substantial goodwill ($9.95 billion) and intangible assets ($4.72 billion), while long-term debt stands at $6.93 billion. Earnings per share were $4.00 (basic and diluted). The company returned capital to shareholders through $190.3 million in dividends and $487.0 million in share repurchases. No prior year comparative figures are provided in the source data, limiting year-over-year analysis.

Key Takeaways